{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:56:18Z","timestamp":1780534578029,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,1,27]],"date-time":"2007-01-27T00:00:00Z","timestamp":1169856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,1,27]],"date-time":"2007-01-27T00:00:00Z","timestamp":1169856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00259-006-0355-4","type":"journal-article","created":{"date-parts":[[2007,1,26]],"date-time":"2007-01-26T15:24:07Z","timestamp":1169825047000},"page":"1219-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin"],"prefix":"10.1007","volume":"34","author":[{"given":"Martijn","family":"van Essen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Krenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem H.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W.","family":"de Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten O.","family":"van Aken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dik J.","family":"Kwekkeboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,27]]},"reference":[{"key":"355_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716\u201331.","journal-title":"Eur J Nucl Med"},{"key":"355_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0140-6736(63)90951-6","volume":"1","author":"ED Williams","year":"1963","unstructured":"Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963;1:238\u20139.","journal-title":"Lancet"},{"key":"355_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00008469-200306000-00004","volume":"12","author":"E Crocetti","year":"2003","unstructured":"Crocetti E, Paci E. Malignant carcinoids in the USA, SEER 1992\u20131999. An epidemiological study with 6830 cases. Eur J Cancer Prev 2003;12:191\u20134.","journal-title":"Eur J Cancer Prev"},{"key":"355_CR4","first-page":"13","volume":"44","author":"G Rindi","year":"2000","unstructured":"Rindi G, Capella C, Solcia E. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Q J Nucl Med 2000;44:13\u201321.","journal-title":"Q J Nucl Med"},{"key":"355_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1183\/09031936.01.00275301","volume":"18","author":"E Brambilla","year":"2001","unstructured":"Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059\u201368.","journal-title":"Eur Respir J"},{"key":"355_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0169-5002(99)00104-X","volume":"27","author":"H Skuladottir","year":"2000","unstructured":"Skuladottir H, Olsen JH, Hirsch FR. Incidence of lung cancer in Denmark: historical and actual status. Lung Cancer 2000;27:107\u201318.","journal-title":"Lung Cancer"},{"key":"355_CR7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0300-2896(15)30484-1","volume":"34","author":"E Pareja","year":"1998","unstructured":"Pareja E, Arnau A, Artigues E, Peiro F, Hostalet F, Martin E, et al. Tumores carcinoides bronquiales: un estudio prospectivo. Arch Bronconeumol 1998;34:71\u20135.","journal-title":"Arch Bronconeumol"},{"key":"355_CR8","first-page":"211","volume":"5","author":"J Soga","year":"1999","unstructured":"Soga J, Yakuwa Y. Bronchopulmonary carcinoids: an analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999;5:211\u20139.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"355_CR9","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-F","volume":"104","author":"G Rindi","year":"1993","unstructured":"Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994\u20131006.","journal-title":"Gastroenterology"},{"key":"355_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.cco.0000147899.04701.c6","volume":"17","author":"A Mulkeen","year":"2005","unstructured":"Mulkeen A, Cha C. Gastric carcinoid. Curr Opin Oncol 2005;17:1\u20136.","journal-title":"Curr Opin Oncol"},{"key":"355_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.bpg.2005.05.002","volume":"19","author":"G Delle Fave","year":"2005","unstructured":"Delle Fave G, Capurso G, Milione M, Panzuto F. Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol 2005;19:659\u201373.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"355_CR12","first-page":"285","volume":"5","author":"J Soga","year":"1999","unstructured":"Soga J, Yakuwa Y, Osaka M. Evaluation of 342 cases of mediastinal\/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999;5:285\u201392.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"355_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0003-4975(98)01063-7","volume":"67","author":"I Fukai","year":"1999","unstructured":"Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, Murase T, et al. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg 1999;67:208\u201311.","journal-title":"Ann Thorac Surg"},{"key":"355_CR14","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","volume":"23","author":"DJ Kwekkeboom","year":"2005","unstructured":"Kwekkeboom DJ, Teunissen JJ, Bakker WH, Kooij PP, de Herder WW, Feelders RA, et al. Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 2005;23:2754\u201362.","journal-title":"J Clin Oncol"},{"key":"355_CR15","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s002590100574","volume":"28","author":"DJ Kwekkeboom","year":"2001","unstructured":"Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion JL, et al. [177Lu-DOTA0Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients. Eur J Nucl Med 2001;28:1319\u201325.","journal-title":"Eur J Nucl Med"},{"key":"355_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00944177","volume":"10","author":"S Green","year":"1992","unstructured":"Green S, Weiss GR. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 1992;10:239\u201353.","journal-title":"Invest New Drugs"},{"key":"355_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934\u201359.","journal-title":"Cancer"},{"key":"355_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00019606-200003000-00008","volume":"9","author":"M Papotti","year":"2000","unstructured":"Papotti M, Croce S, Macri L, Funaro A, Pecchioni C, Schindler M, et al. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung. Diagn Mol Pathol 2000;9:47\u201357.","journal-title":"Diagn Mol Pathol"},{"key":"355_CR19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1023\/A:1012569909313","volume":"12","author":"D Granberg","year":"2001","unstructured":"Granberg D, Eriksson B, Wilander E, Grimfjard P, Fjallskog ML, Oberg K, et al. Experience in treatment of metastatic pulmonary carcinoid tumors. Ann Oncol 2001;12:1383\u201391.","journal-title":"Ann Oncol"},{"key":"355_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.bpg.2005.04.001","volume":"19","author":"JJ Teunissen","year":"2005","unstructured":"Teunissen JJ, Kwekkeboom DJ, de Jong M, Esser JP, Valkema R, Krenning EP. Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy. Best Pract Res Clin Gastroenterol 2005;19:595\u2013616.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"Suppl 1","key":"355_CR21","first-page":"13S","volume":"6","author":"M De Jong","year":"2005","unstructured":"De Jong M, Breeman WA, Valkema R, Bernard BF, Krenning EP. Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs. J Nucl Med 2005;46 Suppl 1:13S\u20137S.","journal-title":"J Nucl Med"},{"key":"355_CR22","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s002590050476","volume":"26","author":"A Otte","year":"1999","unstructured":"Otte A, Herrmann R, Heppeler A, Behe M, Jermann E, Powell P, et al. Yttrium-90 DOTATOC: first clinical results. Eur J Nucl Med 1999;26:1439\u201347.","journal-title":"Eur J Nucl Med"},{"key":"355_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1023\/A:1011160913619","volume":"12","author":"C Waldherr","year":"2001","unstructured":"Waldherr C, Pless M, Maecke HR, Haldemann A, Mueller-Brand J. The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study. Ann Oncol 2001;12:941\u20135.","journal-title":"Ann Oncol"},{"key":"355_CR24","first-page":"610","volume":"43","author":"C Waldherr","year":"2002","unstructured":"Waldherr C, Pless M, Maecke HR, Schumacher T, Crazzolara A, Nitzsche EU, et al. Tumor response and clinical benefit in neuroendocrine tumors after 7.4\u00a0GBq 90Y-DOTATOC. J Nucl Med 2002;43:610\u20136.","journal-title":"J Nucl Med"},{"key":"355_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00259-002-1023-y","volume":"30","author":"L Bodei","year":"2003","unstructured":"Bodei L, Cremonesi M, Zoboli S, Grana C, Bartolomei M, Rocca P, et al. Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study. Eur J Nucl Med Mol Imaging 2003;30:207\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"355_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/j.semnuclmed.2006.01.001","volume":"36","author":"R Valkema","year":"2006","unstructured":"Valkema R, Pauwels S, Kvols LK, Barone R, Jamar F, Bakker WH, et al. Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors. Semin Nucl Med 2006;36:147\u201356.","journal-title":"Semin Nucl Med"},{"key":"355_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/snuc.2002.31769","volume":"32","author":"LB Anthony","year":"2002","unstructured":"Anthony LB, Woltering EA, Espanan GD, Cronin MD, Maloney TJ, McCarthy KE. Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies. Semin Nucl Med 2002;32:123\u201332.","journal-title":"Semin Nucl Med"},{"key":"355_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/snuc\/2002.31025","volume":"32","author":"R Valkema","year":"2002","unstructured":"Valkema R, De Jong M, Bakker WH, Breeman WA, Kooij PP, Lugtenburg PJ, et al. Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: the Rotterdam experience. Semin Nucl Med 2002;32:110\u201322.","journal-title":"Semin Nucl Med"},{"key":"355_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, et al. Affinity profiles for human somatostatin receptor subtypes SST1\u2013SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000;27:273\u201382.","journal-title":"Eur J Nucl Med"},{"key":"355_CR30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s002590100541","volume":"28","author":"JC Reubi","year":"2001","unstructured":"Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1\u2013sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001;28:836\u201346.","journal-title":"Eur J Nucl Med"},{"key":"355_CR31","first-page":"62S","volume":"46","author":"DJ Kwekkeboom","year":"2005","unstructured":"Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, et al. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med 2005;46:62S\u20136S.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0355-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-006-0355-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0355-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0355-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T19:09:36Z","timestamp":1709320176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-006-0355-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,27]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1007\/s00259-006-0355-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,27]]},"assertion":[{"value":"4 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}